Keeping Water Safe: Detecting Pharmaceutical and Personal Care Products in Water Using Liquid Chromatography–Mass Spectrometry
The Application Notebook
Bruker Daltonics
The Problem with PPCPs
Pharmaceutical and personal care products (PPCPs) are products used for personal health or cosmetic reasons. This category includes a broad group of chemical substances such as human and veterinary medicines and cosmetics. The presence of PPCPs in environmental and potable water is a widespread concern due to the potentially harmful environmental effects. Evidence suggests PPCPs are linked to some ecological damage such as delayed development in fish (1).
To ensure the safety of water, PPCP concentrations are stringently monitored by environmental regulatory bodies, including the United States Environmental Protection Agency (US EPA) (2). Detection of PPCPs is traditionally a complicated process due to the range of substances potentially present. Here we explore a simple, more convenient method than traditional solid-phase extraction (SPE)-based methods for highly sensitive PPCP detection, using triple quadrupole liquid chromatography–mass spectrometry (LC–MS–MS).
Figure 1: PPCPs in environmental water and nearby soil is a widespread concern.
Detecting PPCPs
Conventional methods of PPCP detection in clean water have followed the defined EPA 1694 "template" for analysis, which requires the pre-concentration of large volume water samples and tedious solid-phase extraction cleanup, followed by liquid chromatography–mass spectrometry analysis to achieve the low ng/L (ppt) level detection necessary to comply with regulations (3).
Bruker has explored how LC–MS–MS can be employed specifically for the analysis of PPCPs in clean water. PPCPs were detected at 1–2 ppt with a linear response up to 200 or 500 ppt. Excellent system robustness was obtained throughout the extended method development and sample analysis period.
Tables 1a & 1b: Instrumentation set-up for analysis of PPCPs in clean water.
Case Study: Using LC–MS–MS to Analyze PPCPs in Clean Water
The study was carried out using ultrahigh-performance liquid chromatography (UHPLC) with an integrated on-line extraction (OLE) option coupled to a triple quadrupole mass spectrometer. The OLE module enables convenient method-driven on-line sample cleanup or sample pre-concentration.
Figure 2: Selected MRM chromatograms for PPCPs at 2 ppt.
Several water samples were analyzed for a range of PPCP species, including tap water samples along with bottled water and creek water. Samples were analyzed targeting a wide range of PPCP species representing compounds displaying varied properties and concentrations. Tables 1a and 1b illustrate the Advance UHPLC and EVOQ instrumentation set up respectively.
Figure 3: Selected calibration curves.
All of the PPCPs were detected at 2 ppt or better with the injection of 0.4 mL samples with a linear response range up to 200 or 500 ppt. The fast polarity switch can analyze positive and negative PPCPs in the same analytical segment with excellent linear response for both polarities (Figures 2 and 3). The results for the analysis of tap, creek, and bottled waters are shown in Table 2.
Table 2: Test results for selected PPCPs in real water samples.
Conclusion
The Bruker Advance UHPLC with OLE coupled to EVOQ LC–MS–MS detected PPCP samples at 2 ppt or better within 0.4 mL samples. Excellent linearity, sensitivity, and robustness were achieved throughout. The technique presents a more convenient and simpler approach to PPCP analysis than traditional SPE-based methods.
References
(1) K. Hirsch, "Pharmaceuticals and Personal Care Products," (2013). Available at: http://serc.carleton.edu/NAGTWorkshops/health/case_studies/pharmaceutical.html.
(2) US EPA, "PPCPs Basic Information," (2010). Available at: http://www.epa.gov/ppcp/basic2.html.
(3) US EPA, "EPA Method 1694: Pharmaceuticals and Personal Care Products in Water, Soil, Sediment, and Biosolids by HPLC/MS/MS," (2007).
Bruker Daltonics Inc.
40 Manning Road, Billerica, Massachusetts 01821, USA
Tel: (978) 663 3660 Fax: (978) 667 5993
Website: www.bruker.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
